Mitoxantrone and etoposide in patients with relapsed and refractory acute nonlymphocytic leukemia

Haematol Blood Transfus. 1990:33:326-9. doi: 10.1007/978-3-642-74643-7_61.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Drug Evaluation
  • Etoposide / administration & dosage
  • Etoposide / adverse effects
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / mortality
  • Leukemia, Myelomonocytic, Acute / drug therapy*
  • Leukemia, Myelomonocytic, Acute / mortality
  • Mitoxantrone / administration & dosage
  • Mitoxantrone / adverse effects
  • Multicenter Studies as Topic
  • Remission Induction
  • Survival Rate
  • United States / epidemiology

Substances

  • Etoposide
  • Mitoxantrone